Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

HPV DNA Pap Test Approved As Primary Screen; New Guidelines Expected

Apr 07 2003

Related Content

Intervals Lengthened, Costs Lowered By HPV DNA Primary Screening – ACS

Nov 18 2002

Digene SurePath “Not-Approvable” Letter Expected After FDA Data Request

Jul 15 2002

Cytyc Has About $180 Mil. To Invest Following Collapse Of Digene Merger

Jul 08 2002

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window